Health
Regeneron suspends Covid-19 antibody trial among sickest patients – UrduPoint News
US biotech firm Regeneron on Friday said it was suspending enrollment for a study of its Covid-19 antibody treatment among the sickest patients who require high-flow…
Washington, (UrduPoint / Pakistan Point News – 30th Oct, 2020 ) :US biotech firm Regeneron on Friday said it was suspending enrollment for a study of its Covid-19 antibody treatment among the sickest patients who require high-flow oxygen or are on ventilators.
The move follows a recommendation from an independent data monitoring committee (IDMC) which assesses the results and advises when it’s necessary to halt a study.
“Based on a potential safety signal and an unfavorable risk/benefit profile…
-
General23 hours agoGymnastics club in Berwick shuts down following child safety complaint
-
General16 hours agoAshes engulfed by fresh DRS controversy as TV umpire gives Jamie Smith out despite RTS ‘murmur’
-
General19 hours ago‘Mother’s Day’ solar storm squeezed Earth’s plasmasphere to one-fifth its size
-
Noosa News21 hours agoMeticulously crafted home in heart of Noosa Heads